The above corresponds to the activation and response of MAPK1 and PRKCB in the experiments, which confirms that MAPK1 and PRKCB may play important roles in the process of estero toadstool ligands in renal cell carcinoma and lays the foundation for the subsequent experiments. This evidence concerns the gene PRKCB and renal cell carcinoma.